The GALA trial: Will it influence clinical practice?

Vascular and Endovascular Surgery

Volumn 43, Issue 5, 2009, Pages 429-432

  Paraskevas, Kosmas I ^a   Mikhailidis, Dimitri P ^b   Bell, Peter R F ^c,d  

^a RED CROSS HOSPITAL   (Greece)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Carotid endarterectomy; GALA; Shunts; Stroke

Indexed keywords

ANESTHETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOCAL ANESTHETIC AGENT;

CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; GENERAL ANESTHESIA; HEART INFARCTION; HUMAN; LOCAL ANESTHESIA; MEDICAL INFORMATION; MORTALITY; PROPHYLAXIS; SHORT SURVEY; STROKE; SURGEON; TREATMENT OUTCOME;

ANESTHESIA, GENERAL; ANESTHESIA, LOCAL; CAROTID STENOSIS; ENDARTERECTOMY, CAROTID; HUMANS; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE;

EID: 70350517283     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/1538574409340589     Document Type: Short Survey

References (22)

1. GALA Trial Collaborative Group. Lewis SC, Warlow CP, Bodenham AR, et al. General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial. Lancet. 2008 ; 372 (9656). 2132-2142.
2. Paraskevas KI, Mikhailidis DP Anaesthetic techniques for carotid surgery. Lancet. 2009 ; 373 (9666). 807.
3. Lewis S., Gough M., Bodenham A., Warlow C. Anaesthetic techniques for carotid surgery-authors reply. Lancet. 2009 ; 373 (9666). 807-808.
4. McGirt MJ, Perler BA, Brooke BS, et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg. 2005 ; 42 (5). 829-836.
5. Ridker PM, Danielson E., Fonseca FA, et al. JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008 ; 359 (21). 2195-2207.
6. The SPARCL Investigators. Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006 ; 355 (6). 549-559.
7. Sillesen H., Amarenco P., Hennerici MG, et al. Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2008 ; 39: 3297-3302.
8. McCleary AJ, Dearden NM, Dickson DH, Watson A., Gough MJ The differing effects of regional and general anaesthesia on cerebral metabolism during carotid endarterectomy. Eur J Vasc Endovasc Surg. 1996 ; 12 (2). 173-181.
9. Bellosta R., Luzzani L., Carugati C., Talarico M., Sarcina A. Routine shunting is a safe and reliable method of cerebral protection during carotid endarterectomy. Ann Vasc Surg. 2006 ; 20 (4). 482-487.
10. Roseborough GS Pro: routine shunting is the optimal management of the patient undergoing carotid endarterectomy. J Cardiothorac Vasc Anesth. 2004 ; 18 (3). 375-380.
11. Toronto Cerebrovascular Study Group. Risks of carotid endarterectomy. Stroke. 1986 ; 17 (5). 848-852.
12. Zampella E., Morawetz RB, McDowell HA, et al. The importance of cerebral ischemia during carotid endarterectomy. Neurosurgery. 1991 ; 29 (5). 727-730.
13. Steiger HJ, Schaffler L., Boll J., Liechti S. Results of microsurgical carotid endarterectomy. A prospective study with transcranial Doppler and EEG monitoring, and elective shunting. Acta Neurochir (Wien). 1989 ; 100 (1-2). 31-38.
14. Nguyen TQ, Lind L., Harris EJ Jr. Selective shunting during carotid endarterectomy. Vascular. 2005 ; 13 (1). 23-27.
15. Halsey JH Jr. Risks and benefits of shunting in carotid endarterectomy. The International Transcranial Doppler Collaborators. Stroke. 1992 ; 23 (11). 1583-1587.
16. Bond R., Rerkasem K., Counsell C., et al. Routine or selective carotid artery shunting for carotid endarterectomy (and different methods of monitoring in selective shunting). Cochrane Database Syst Rev. 2002 ;(2). CD000190.
17. Woodworth GF, McGirt MJ, Than KD, Huang J., Perler VA, Tamargo RJ Selective versus routine intraoperative shunting during carotid endarterectomy: a multivariate outcome analysis. Neurosurgery. 2007 ; 61 (6). 1170-1176.
18. Guay J. The GALA trial: answers it gives, answers it does not. Lancet. 2008 ; 372 (9656). 2092-2093.
19. Girn HR, Dellagrammaticas D., Laughlan K., Gough MJ GALA Trial Collaborators. Carotid endarterectomy: technical practices of surgeons participating in the GALA trial. Eur J Vasc Endovasc Surg. 2008 ; 36 (4). 385-389.
20. Dilaveris P., Giannopoulos G., Riga M., Synetos A., Stefanadis C. Beneficial effects of statins on endothelial dysfunction and vascular stiffness. Curr Vasc Pharmacol. 2007 ; 5 (3). 227-237.
21. Gelosa P., Cimino M., Pignieri A., Tremoli E., Guerrini U., Sironi L. The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation. Vasc Health Risk Manag. 2007 ; 3 (5). 567-577.
22. Paraskevas KI, Hamilton G., Mikhailidis DP Statins: an essential component in the management of carotid artery disease. J Vasc Surg. 2007 ; 46 (2). 373-386.